Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

Spotlight on Mental Health Centers of Excellence

Opioid and Benzodiazepine Co-prescribing and Mortality among VA Patients with Posttraumatic Stress Disorder


by Eric Hawkins, PhD ; Carol Malte, MSW
Seminar date: 6/11/2018

Description: This presentation will present the results of a retrospective cohort study that assesses the comparative safety of co-prescribing opioids and benzodiazepines among 17,476 patients receiving Veteran Affairs (VA) health care and diagnosed with posttraumatic stress disorder (PTSD). We will compare the relative risk of all-cause mortality among VA patients with PTSD who received new opioid and benzodiazepine therapies concurrently, as compared to propensity-score matched patients who received drugs from only one of or neither of these medication classes. We will also present the risk of death by overdose, circulatory and respiratory-related causes among patients newly co-prescribed opioids and benzodiazepines, relative to patients who are prescribed opioids only, benzodiazepines only or neither medication. Intended Audience: providers, policy makers, and health services researchers.



DOWNLOAD: PDF handout | Audio only (mp3) | transcript


Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.